Island Pharmaceuticals Ltd has released a press release.
Options exercised raises $1million
Filed with ASX ·
6ix hasn’t read this filing yet.
Island Pharmaceuticals Ltd on 6ix
Earlier from Island Pharmaceuticals
- Coalition acceptance to advance US procurement & stockpiling
- Island engages advisers to advance biodefence strategy
- FDA agrees Animal Rule pathway and PRV eligibility
- FDA confirms response timing for Galidesivir
- US FDA Type C meeting briefing document submitted
Later from Island Pharmaceuticals
- Additional FDA Submission completed for Galidesivir
- Island expands Galidesivir IP with US Patent Grant
- Agreement with Texas Biomed for Galidesivir Program
- Ongoing engagement with the US FDA
- US Patent Granted for Galidesivir in filoviridae viruses
Follow Island Pharmaceuticals into a list and get an email when it puts out news.
Follow Island Pharmaceuticals